SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
60.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (3.39%)
Market Cap: £47.29m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Board Changes

3 Dec 2024 07:00

RNS Number : 5000O
Hardide PLC
03 December 2024
 

The information contained within this announcement is deemed by Hardide to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. 

 

3 December 2024

 

Hardide plc

("Hardide", "the Group" or "the Company")

 

Appointment of Dr. Bryan Allcock as an Independent Non-Executive Director

 

Hardide plc, the provider of advanced surface treatment solutions, is pleased to announce the appointment of Dr. Bryan Allcock to the Board today as an Independent Non-Executive Director. Bryan will succeed Tim Rice as Hardide's Senior Independent Director and Chair of the Remuneration Committee with effect from 1 January 2025, as Tim will be stepping down from the Board on 31 December 2024.

 

Bryan has career long experience working in the advanced materials, surface engineering and coatings industry.

 

He is currently CEO of his own business, TRL9 Limited, which runs a portfolio of research, development and deployment projects, including the use of high entropy alloys. Bryan acts as a subject matter expert to the Ministry of Defence and BAE Systems for the coating of flight decks for Queen Elizabeth Class aircraft carriers and has collaborative research contracts with Jaguar Land Rover, the Defence and Security Accelerator (DASA) and the European Space Agency.

 

Bryan was formerly Global CEO for the Services business of Castolin Eutectic Limited, part of the Messer Group, where he ran an international £56m revenue business delivering surface engineering and advanced coating solutions. Bryan joined Castolin Eutectic having sold his own business, Monitor Coatings, to them in 2013.

 

Bryan spent his earlier career as Head of Technical Services at Flight Refuelling Limited, part of Cobham plc, where he grew profits significantly through business development of the coatings division, operational improvement and efficiency initiatives.

 

Bryan holds an MBA, has a degree in applied chemistry and materials, and holds a PhD in Corrosion Engineering from Cranfield University. He is a fellow of the Institute of Materials, Minerals and Mining and has been a strategic advisor to the Institute.

 

Further information regarding Bryan Allcock, as required by Schedule 2(g) of the AIM Rules for Companies, is set out below.

 

Andrew Magson, Non-Executive Chair, commented:

 

"We are delighted that Bryan is joining the Hardide Board. He has a deep understanding of the coatings and surface treatment sectors and a rare combination of technical, business development, sales and marketing skills. Together with an entrepreneurial mind-set, this means his knowledge and experience is highly aligned with Hardide's strategy of better commercialising the business and accelerating revenue growth.

 

I'd also like to place on record the Board's thanks to Tim Rice, who has provided wise counsel to all of us during his six years of service as our Senior Independent Director. Tim was instrumental to Hardide's success in developing its business with the aerospace sector. We wish him well for the future."

 

 

Dr. Bryan Allcock BSc (Hons) PhD, MBA, FIMMM (Age 57)

 

Current Directorships:

 

TRL9 Limited

Solar Fluidics UK Limited

Burgham Park Residents Association Limited

Zonne Limited

UVCR Limited

 

Past Directorships in the last 5 years:

 

None.

 

Bryan Allcock does not own any ordinary shares or options over ordinary shares in the Company.

 

There is no further information on Bryan Allcock required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

 

 

For further information:

Hardide plc

Andrew Magson (Non-Executive Chair)

Tim Rice (Senior Independent Director)

Matt Hamblin (CEO)

 

Tel: +44 (0) 1869 353 830

 

 

 

Cavendish Capital Markets Ltd - Nominated Adviser and Broker

Henrik Persson/ Abigail Kelly / Elysia Bough (Corporate Finance)

Jasper Berry / Dale Bellis (Sales)

 

Tel: +44 (0) 2072 200 500

 

Notes to editors:

www.hardide.com

 

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency as well as a reduced carbon footprint. Customers include leading companies operating in the energy sectors, valve and pump manufacturing, industrial gas turbine, precision engineering and aerospace industries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFITFSLFIIS
Date   Source Headline
22nd Feb 20167:00 amRNSAGM Statement
7th Jan 20167:00 amRNSUpdate on US facility
30th Dec 20157:00 amRNSExercise of Options
18th Dec 20157:00 amRNSMajor order and diversification success
17th Dec 20157:00 amRNSAirbus Technical Update
7th Dec 20157:00 amRNSPreliminary Results
5th Oct 20157:00 amRNSPre-Close Trading Update
10th Sep 20153:19 pmRNSDirector Option Award
21st May 20157:00 amRNSInterim Results
12th May 20157:01 amRNSSenior Management Appointment
29th Apr 20157:00 amRNSTrading Update
23rd Mar 20157:00 amRNSAgreement Extension with General Electric
2nd Mar 20157:00 amRNSDirectorate Change
9th Feb 201512:31 pmRNSResult of AGM
9th Feb 20157:00 amRNSAGM Statement
22nd Jan 20157:00 amRNSMajor investment in new production facility in US
19th Jan 201510:30 amRNSDirector Dealing
25th Nov 20147:00 amRNSPreliminary Results
28th Oct 20149:15 amRNSInstallation of Third Large Capacity Reactor
18th Sep 20147:00 amRNSTrading Update
27th Aug 201410:00 amRNSHolding(s) in Company
18th Aug 20146:20 pmRNSHolding(s) in Company
18th Aug 201412:06 pmRNSHolding(s) in Company
14th Aug 201411:29 amRNSResult of General Meeting and Placing completion
6th Aug 201411:15 amRNSHolding(s) in Company
1st Aug 20141:59 pmRNSConversion of Loan Note
22nd Jul 20147:00 amRNSAirbus Test Programme Update
22nd Jul 20147:00 amRNSConditional Placing to Raise £2.7 million
9th Jun 20144:29 pmRNSConversion of Loan Note
28th May 20147:00 amRNSInterim Results
14th May 20147:00 amRNSHolding in Company
8th May 201410:05 amRNSHolding(s) in Company
30th Apr 20147:00 amRNSTrading Update
18th Mar 20141:45 pmRNSHolding(s) in Company
17th Mar 201412:37 pmRNSHolding(s) in Company
14th Mar 201412:45 pmRNSHolding(s) in Company
12th Mar 20144:15 pmRNSHolding(s) in Company
11th Mar 20147:00 amRNSConversion of Loan Note
3rd Mar 20147:00 amRNSMajor Supply Agreement with General Electric
10th Feb 201412:04 pmRNSResult of AGM
10th Feb 20149:00 amRNSAGM Statement
6th Feb 201411:56 amRNSStatement re: share price movement
23rd Jan 20144:27 pmRNSChange of Adviser
4th Dec 20137:00 amRNSHardide aims high for prestigious Nadcap approval
25th Nov 20137:00 amRNSPreliminary results
9th Jul 20132:29 pmRNSDirector/PDMR Shareholding
1st Jul 20137:00 amRNSAgustaWestland Replacement Test Success
18th Jun 20137:00 amRNSInterim Results
29th Apr 20137:00 amRNSRe Agreement
24th Apr 20137:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.